Creative Medical Technology Holdings Inc. (CELZ)
CELZ trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.8199
-2.51% on the day
Market cap
$6.2M
Nano cap
Revenue · 2025
$6K
-45.5% on 2024
Net income · 2025
-$6.0M
-99916.8% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | CELZ on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001187953 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | NV |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $6K |
| Net income | -$6.0M |
| Operating income | -$6.1M |
| Net margin | -99916.8% |
| Operating margin | -102380.2% |
| Revenue growth | -45.5% |
| Cash | Not in SEC XBRL data |
| Total assets | $7.8M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1037.5× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-08-03 |
| Latest annual report FORM 10-K/A | 10-K/A | 2026-04-24 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-08-07 |
| Latest current report FORM 8-K | 8-K | 2026-09-25 |
| Latest proxy | DEF 14A | 2026-07-14 |
Source: SEC EDGAR submissions feed, 409 recent filings. All filings on EDGAR.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| BTTC | Black Titan Corporation | $0.4380 | -10.70% | $6.0M |
| AIM | AIM ImmunoTech Inc. | $0.1699 | -4.23% | $6.8M |
| SNTI | Senti Biosciences Holdings Inc. | $0.2550 | -19.96% | $7.9M |
| LIMN | Liminatus Pharma Inc. | $3.41 | -1.16% | $4.6M |
| PMCB | PharmaCyte Biotech Inc. | $0.3559 | -2.52% | $3.8M |
| INTS | Intensity Therapeutics Inc. | $3.55 | +7.25% | $11.6M |
| INAB | IN8bio Inc. | $1.18 | -4.07% | $11.6M |
| CLDI | Calidi Biotherapeutics Inc. | $0.8999 | -5.26% | $3.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier